C-reactive protein and the acute phase reaction in geriatric patients;C-reaktives Protein und die Akute-Phase-Reaktion bei geriatrischen Patienten

Zeitschrift fur Gerontologie und Geriatrie

Volumn 48, Issue 7, 2015, Pages 595-600

  Bertsch, Thomas ^a   Triebel, Jakob ^a   Bollheimer, Cornelius ^b,c   Christ, Michael ^d   Sieber, Cornel ^b,c   Fassbender, Klaus ^e   Heppner, Hans Jürgen ^f  

^a PARACELSUS MEDICAL UNIVERSITY   (Germany)

^b Saint John of God Hospital Regensburg   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d PARACELSUS MEDICAL UNIVERSITY   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

^f Helios Klinikum Schwelm   (Germany)

Author keywords

Acute phase reaction; C reactive protein; Geriatrics; Infection; Innate immune response

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE;

ACUTE PHASE RESPONSE; AGED; BLOOD; DIAGNOSIS; FEMALE; GERIATRIC ASSESSMENT; HUMAN; IMMUNOLOGY; MALE; PROCEDURES; RISK ASSESSMENT; VERY ELDERLY;

ACUTE-PHASE REACTION; AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; RISK ASSESSMENT;

EID: 84943453673     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-015-0938-4     Document Type: Article

References (53)

1. Abernethy TJ, Avery OT (1941) The occurrence during acute infections of a protein not normally present in the blood: I. distribution of the reactive protein in patients’ sera and the effect of calcium on the flocculation reaction with C polysaccharide of pneumococcus. J Exp Med 73:173–182
2. Ball EM, Gibson DS, Bell AL et al (2014) Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus. Lupus 23:46–56
3. Banks RE, Forbes MA, Patel PM et al (2000) Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: pharmacokinetics, pharmacodynamics and immunomodulatory effects. Cytokine 12:388–396
4. Behnes M, Bertsch T, Lepiorz D et al (2014) Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 18:507
5. Bertsch T, Banks RE, Forbes MA et al (1996) Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancer. Ann Clinl Biochem 33:565–567
6. Bodman-Smith KB, Melendez AJ, Campbell I et al (2002) C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI). Immunology 107:252–260
7. Boenisch S, Fae P, Drexel H et al (2013) Are circulating levels of CRP compared to IL-6 and PCT still relevant in intensive care unit patients? (English Version). J Lab Med. doi:10.1515/labmed-2013-0029
8. Boenisch S, Fae P, Drexel H et al (2013) Spielen CRP-Spiegel neben IL-6 und PCT noch eine Rolle für Patienten auf Intensivstationen?/Are circulating levels of CRP compared to IL-6 and PCT still relevant in intensive care unit patients? (German Version). J Lab Med 37:1–11. doi:10.1515/labmed-2012-0010
9. Brunkhorst R, Eberhardt OK, Haubitz M et al (2000) Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med 26(Suppl 2):S199–201
10. Calabro P, Chang DW, Willerson JT et al (2005) Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol 46:1112–1113
11. Chun HY, Chung JW, Kim HA et al (2007) Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 27:461–466
12. Desai A, Grolleau-Julius A, Yung R (2010) Leukocyte function in the aging immune system. J Leukoc Biol 87:1001–1009
13. Dong Q, Wright JR (1996) Expression of C-reactive protein by alveolar macrophages. J Immunol 156:4815–4820
14. Du Clos TW (1989) C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J Immunol 143:2553–2559
15. Du Clos TW (2013) Pentraxins: structure, function, and role in inflammation. ISRN Inflamm 2013:379040
16. Du Clos TW, Marnell L, Zlock LR et al (1991) Analysis of the binding of C-reactive protein to chromatin subunits. J Immunol 146:1220–1225
17. Ehrich JH, Krull F, Peltner U et al (1986) [Significance of C-reactive protein in pediatric diagnosis]. Monatsschr Kinderheilkd 134:840–846
18. Gaitonde S, Samols D, Kushner I (2008) C-reactive protein and systemic lupus erythematosus. Arthritis Rheum 59:1814–1820
19. Gomez CR, Nomellini V, Faunce DE et al (2008) Innate immunity and aging. Exp Gerontol 43:718–728
20. Heinrich PC, Müller M, Graeve L (2014) Löffler/Petrides Biochemie und Pathobiochemie. Springer-Verlag, Berlin
21. Heppner HJ, Bertsch T, Alber B et al (2010) Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia - a clinical observation in geriatric patients. Gerontology 56:385–389
22. Hind CR, Winearls CG, Pepys MB (1985) Correlation of disease activity in systemic vasculitis with serum C-reactive protein measurement. A prospective study of thirty-eight patients. Eur J Clin Invest 15:89–94
23. Hutchinson WL, Noble GE, Hawkins PN et al (1994) The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest 94:1390–1396
24. Illei GG, Tackey E, Lapteva L et al (2004) Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 50:2048–2065
25. Juma WM, Lira A, Marzuk A et al (2011) C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion. Brain Res 1414:85–93
26. Knudsen LS, Klarlund M, Skjodt H et al (2008) Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome. J Rheum 35:1277–1287
27. Kuta AE, Baum LL (1986) C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. J Exp Med 164:321–326
28. Lapin A, Bohmer F (2005) Laboratory diagnosis and geriatrics: more than just reference intervals for the elderly. Wien Med Wochenschr 155:30–35
29. Lee SH, Chan RC, Wu JY et al (2013) Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systemic review and meta-analysis. Int J Clin Pract 67:1350–1357
30. Liu A, Bui T, Van Nguyen H et al (2010) Serum C-reactive protein as a biomarker for early detection of bacterial infection in the older patient. Age Ageing 39:559–565
31. Marnell LL, Mold C, Volzer MA et al (1995) C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol 155:2185–2193
32. Mold C, Gewurz H, Du Clos TW (1999) Regulation of complement activation by C-reactive protein. Immunopharmacology 42:23–30
33. Müller-Esterl W (2010) Biochemie - Eine Einführung für Mediziner und Naturwissenschaftler. Spektrum Akademischer Verlag, Heidelberg
34. Ohl K, Tenbrock K (2011) Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol 2011:432595
35. Oliveira EB, Gotschlich EC, Liu TY (1977) Primary structure of human C-reactive protein. Proc Natl Acad Sci U S A 74:3148–3151
36. Opal SM, Girard TD, Ely EW (2005) The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 41(Suppl 7):S504–512
37. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812
38. Pepys MB, Baltz M, Gomer K et al (1979) Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278:259–261
39. Pepys MB, Dash AC, Markham RE et al (1978) Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol 32:119–124
40. Rossol M, Heine H, Meusch U et al (2011) LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 31:379–446
41. Shrivastava AK, Singh HV, Raizada A et al (2015) Inflammatory markers in patients with rheumatoid arthritis. Allergol Immunopathol (Madr) 43:81–87
42. Shrive AK, Cheetham GM, Holden D et al (1996) Three dimensional structure of human C-reactive protein. Nat Struct Biol 3:346–354
43. Singler K, Bertsch T, Heppner HJ et al (2013) Diagnostic accuracy of three different methods of temperature measurement in acutely ill geriatric patients. Age Ageing 42:740–746
44. Stuart RA, Littlewood AJ, Maddison PJ et al (1995) Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin Exp Rheumatol 13:17–22
45. Talebi-Taher M, Babazadeh S, Barati M et al (2014) Serum inflammatory markers in the elderly: are they useful in differentiating sepsis from SIRS? Acta Med Iran 52:438–442
46. Tillett WS, Francis T (1930) Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 52:561–571
47. Tron K, Manolov DE, Rocker C et al (2008) C-reactive protein specifically binds to Fcgamma receptor type I on a macrophage-like cell line. Eur J Immunol 38:1414–1422
48. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426–431
49. Vigushin DM, Pepys MB, Hawkins PN (1993) Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 91:1351–1357
50. Volanakis JE (1982) Complement activation by C-reactive protein complexes. Ann N Y Acad Sci 389:235–250
51. Volanakis JE, Wirtz KW (1979) Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature 281:155–157
52. Walston J, Mcburnie MA, Newman A et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162:2333–2341
53. Wester AL, Blaasaas KG, Wyller TB (2008) Is the concentration of C-reactive protein in bacteraemia associated with age? Immun Ageing 5:8